IJGPNInternational Journal of General Practice Nursing2981-94152981-9423Bio-Byword Scientific Publishing Pty. Ltd.10.26689/ijgpn.v4i2.15065ArticleCurrent Status and Influencing Factors of Cardiovascular and Metabolic Comorbidities in Ischemic Stroke Patientshttps://artdesignp.com/journal/IJGPN/4/2/10.26689/ijgpn.v4i2.15065YangHui,WangNa,WangMenghe,ZhengRibo2026422026-05-31This study aims to explore the epidemiological characteristics, influencing factors, and specific impacts on clinical prognosis of cardiometabolic multimorbidity (CMC) in patients with ischemic stroke. By analyzing the clinical data of 864 hospitalized patients with ischemic stroke, the study found that CMC is highly prevalent in this population, with an overall prevalence of 68.29%, among which hypertension, dyslipidemia, and diabetes mellitus are the most common types of comorbidities. Multivariable Logistic regression analysis revealed that advanced age, smoking, high salt intake, and lower socioeconomic status are key risk factors for the occurrence of CMC. Regarding the impact on prognosis, this study confirmed that the CMC status significantly increases the risk of the first stroke occurrence, which grows exponentially with the number of metabolic abnormalities. Follow-up data showed that the one-year recurrence rate in the CMC group (15.68%) was significantly higher than that in the non-CMC group (9.24%). Furthermore, patients with CMC exhibited more severe neurological deficits during the acute phase and slower recovery of long-term activities of daily living. Based on these findings, the study proposes the construction of a full-chain management system ranging from primary prevention to intensive secondary prevention, emphasizing the central role of the Multidisciplinary Team (MDT) model in improving the prognosis of patients with complex multimorbidity. This study provides important evidence-based medical grounds for optimizing clinical management pathways and public health prevention strategies for stroke patients in China.

Chen XR, Yan LX, Long Z, et al., 2025, Analysis of the Incidence and Mortality Characteristics of Ischemic and Hemorrhagic Stroke among Chinese Residents from 2015 to 2019. Chinese Journal of Preventive Medicine, 59(2): 2022–208. https://doi.org/10.3760/cmaj.cn112150-20240412-00299

Chen YY, Liu PZ, Wang CL, 2024, The Current Status of Research on Comorbidities in the Elderly and Its Implications for Comorbidity Management. Chinese Medical Journal, 26(7): 731–736. https://doi.org/10.3969/j.issn.1009-0959.2024.07.027

Mulugeta A, Hyppnen E, Ala-Korpela M, et al., 2021, Metabolic Subgroups and Cardiometabolic Multimorbidity in the UK Biobank. Cold Spring Harbor Laboratory Press, preprint. https://doi.org/10.1101/2021.02.01.21250893

Batista SR, Vitorino PVO, Silva RR, et al., 2022, Cardiometabolic Multimorbidity and Associated Factors: The First Brazilian Registry of Patients with Hypertension. Journal of Hypertension, 40(6-Sup1): 1. https://doi.org/10.1097/01.hjh.0000836956.49814.5d

Han K, Jia WP, Cao WZ, et al., 2020, Distribution Characteristics and Influencing Factors of Cardiovascular Metabolic Diseases in 1591 Elderly Patients with Esophageal Cancer. Chinese Journal of Geriatric Multiple Organ Diseases, 19(12): 5.

Wang JT, Wang ZJ, Wu YQ, et al., 2021, Prevalence and Characteristics of Common Comorbidity of 1.15 Million Type 2 Diabetes Patients in Beijing. Journal of the Third Military Medical University, 43(12): 7. https://doi.org/10.16016/j.1000-5404.202101017